Clinical Trial Update: Nanocrystalline Megestrol for Managing Chemotherapy-Induced Nausea and Vomiting [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating nanocrystalline megestrol for preventing chemotherapy-induced nausea and vomiting in patients receiving moderately to highly e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Nanocrystalline Megestrol (Megestrol acetate)

Snippet

Sponsor: The First Affiliated Hospital of Xinxiang Medical College | Conditions: Malignant Solid Tumors, Moderate to High Emetogenic Chemotherapy (MEC/HEC) Drugs | Phase 3 | Status: NOT_YET_RECRUITING